These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 11717448)

  • 1. Adeno-associated virus vector-mediated IL-10 gene delivery prevents type 1 diabetes in NOD mice.
    Goudy K; Song S; Wasserfall C; Zhang YC; Kapturczak M; Muir A; Powers M; Scott-Jorgensen M; Campbell-Thompson M; Crawford JM; Ellis TM; Flotte TR; Atkinson MA
    Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13913-8. PubMed ID: 11717448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant adeno-associated virus-mediated alpha-1 antitrypsin gene therapy prevents type I diabetes in NOD mice.
    Song S; Goudy K; Campbell-Thompson M; Wasserfall C; Scott-Jorgensen M; Wang J; Tang Q; Crawford JM; Ellis TM; Atkinson MA; Flotte TR
    Gene Ther; 2004 Jan; 11(2):181-6. PubMed ID: 14712302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene delivery GAD 500 autoantigen by AAV serotype 1 prevented diabetes in NOD mice: transduction efficiency do not play important roles.
    Han G; Wang R; Chen G; Wang J; Xu R; Feng J; Yu M; Wu X; Qian J; Shen B; Li Y
    Immunol Lett; 2008 Jan; 115(2):110-6. PubMed ID: 18045698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of adoptively transferred diabetes in nonobese diabetic mice with IL-10-transduced islet-specific Th1 lymphocytes. A gene therapy model for autoimmune diabetes.
    Moritani M; Yoshimoto K; Ii S; Kondo M; Iwahana H; Yamaoka T; Sano T; Nakano N; Kikutani H; Itakura M
    J Clin Invest; 1996 Oct; 98(8):1851-9. PubMed ID: 8878437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic overexpression of IL-10 induces CD4+CD25+ cell populations in vivo and ameliorates type 1 diabetes in nonobese diabetic mice in a dose-dependent fashion.
    Goudy KS; Burkhardt BR; Wasserfall C; Song S; Campbell-Thompson ML; Brusko T; Powers MA; Clare-Salzler MJ; Sobel ES; Ellis TM; Flotte TR; Atkinson MA
    J Immunol; 2003 Sep; 171(5):2270-8. PubMed ID: 12928371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy of spontaneous type 1 diabetes in nonobese diabetic mice by systemic interleukin-4 treatment employing adenovirus vector-mediated gene transfer.
    Cameron MJ; Arreaza GA; Waldhauser L; Gauldie J; Delovitch TL
    Gene Ther; 2000 Nov; 7(21):1840-6. PubMed ID: 11110416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intramuscular administration of expression plasmids encoding interferon-gamma receptor/IgG1 or IL-4/IgG1 chimeric proteins protects from autoimmunity.
    Chang Y; Prud'homme GJ
    J Gene Med; 1999; 1(6):415-23. PubMed ID: 10753067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TGF-beta1 somatic gene therapy prevents autoimmune disease in nonobese diabetic mice.
    Piccirillo CA; Chang Y; Prud'homme GJ
    J Immunol; 1998 Oct; 161(8):3950-6. PubMed ID: 9780163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined administration of plasmids encoding IL-4 and IL-10 prevents the development of autoimmune diabetes in nonobese diabetic mice.
    Ko KS; Lee M; Koh JJ; Kim SW
    Mol Ther; 2001 Oct; 4(4):313-6. PubMed ID: 11592833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inducible adeno-associated virus-mediated IL-2 gene therapy prevents autoimmune diabetes.
    Goudy KS; Johnson MC; Garland A; Li C; Samulski RJ; Wang B; Tisch R
    J Immunol; 2011 Mar; 186(6):3779-86. PubMed ID: 21317396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination therapy with low dose sirolimus and tacrolimus is synergistic in preventing spontaneous and recurrent autoimmune diabetes in non-obese diabetic mice.
    Shapiro AM; Suarez-Pinzon WL; Power R; Rabinovitch A
    Diabetologia; 2002 Feb; 45(2):224-30. PubMed ID: 11935154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Th17 polarized cells from nonobese diabetic mice following mycobacterial adjuvant immunotherapy delay type 1 diabetes.
    Nikoopour E; Schwartz JA; Huszarik K; Sandrock C; Krougly O; Lee-Chan E; Singh B
    J Immunol; 2010 May; 184(9):4779-88. PubMed ID: 20363968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of autoimmune diabetes by immunogene therapy using recombinant vaccinia virus expressing glutamic acid decarboxylase.
    Jun HS; Chung YH; Han J; Kim A; Yoo SS; Sherwin RS; Yoon JW
    Diabetologia; 2002 May; 45(5):668-76. PubMed ID: 12107747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A noncytolytic IL-10/Fc fusion protein prevents diabetes, blocks autoimmunity, and promotes suppressor phenomena in NOD mice.
    Zheng XX; Steele AW; Hancock WW; Stevens AC; Nickerson PW; Roy-Chaudhury P; Tian Y; Strom TB
    J Immunol; 1997 May; 158(9):4507-13. PubMed ID: 9127018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viral IL-10-mediated immune regulation in pancreatic islet transplantation.
    Carter JD; Ellett JD; Chen M; Smith KM; Fialkow LB; McDuffie MJ; Tung KS; Nadler JL; Yang Z
    Mol Ther; 2005 Aug; 12(2):360-8. PubMed ID: 16043104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adeno-associated virus-mediated IL-10 gene therapy inhibits diabetes recurrence in syngeneic islet cell transplantation of NOD mice.
    Zhang YC; Pileggi A; Agarwal A; Molano RD; Powers M; Brusko T; Wasserfall C; Goudy K; Zahr E; Poggioli R; Scott-Jorgensen M; Campbell-Thompson M; Crawford JM; Nick H; Flotte T; Ellis TM; Ricordi C; Inverardi L; Atkinson MA
    Diabetes; 2003 Mar; 52(3):708-16. PubMed ID: 12606512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-10 plasmid construction and delivery for the prevention of type 1 diabetes.
    Lee M; Park H; Youn J; Oh ET; Ko K; Kim S; Park Y
    Ann N Y Acad Sci; 2006 Oct; 1079():313-9. PubMed ID: 17130572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of autoimmune diabetes by viral IL-10 gene transfer.
    Yang Z; Chen M; Wu R; Fialkow LB; Bromberg JS; McDuffie M; Naji A; Nadler JL
    J Immunol; 2002 Jun; 168(12):6479-85. PubMed ID: 12055268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A murine interleukin-4-Ig fusion protein regulates the expression of Th1- and Th2-specific cytokines in the pancreas of NOD mice.
    Walz M; Overbergh L; Mathieu C; Kolb H; Martin S
    Horm Metab Res; 2002 Oct; 34(10):561-9. PubMed ID: 12439784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. dsAAV8-mediated gene transfer and β-cell expression of IL-4 and β-cell growth factors are capable of reversing early-onset diabetes in NOD mice.
    Gaddy DF; Riedel MJ; Bertera S; Kieffer TJ; Robbins PD
    Gene Ther; 2012 Aug; 19(8):791-9. PubMed ID: 22089495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.